Tokyo, Aug. 19 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000058826) titled 'Comparative study of human absorption of Q10 formulation -3 (NO fasting condition)' on Aug. 19.
Study Type:
Interventional
Study Design:
Basic Design - Cross-over
Randomization - Randomized
Blinding - Double blind -all involved are blinded
Control - Active
Primary Sponsor:
Institute - KANEKA CORPORATION
Condition:
Condition - None
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To compare the absorbability of two Q10 formulations in humans in NO fasting condition.
Basic objectives2 - Bio-equivalence
Intervention:
Interventions/Control_1 - Single intake of test f...